New Antifungal Drugs, New Approaches and Vaccines Antifungal name Choose antifungalAlbaconazoleAlpha-asaroneAmorolfineAR-12ASP2397 (VL-2397)ASP9726AuranofinAureobasidin ABHBMBiafungin (CD101)CD101Ceragenin CSA-131CorifunginE1210Encochleated AmB (MAT023)EV-086F901318 (olorofim)FG 3622FK506 (tacrolimus) and L-685,818FR290581General articlesGM 237354GriseofulvinHaemofunginIbomycinIbrexafungerp (SCY-078, MK-3118)Icofungipen (PLD-118)Ilicicolin HKOSN-2079 (polyketide)L365L743L884Macrocyclic amidinoureasManumycin AMAT2203MGCD290MycograbMyriocinNebulised AmpBNikkomycin ZNovamycin (NP339)Novexatin (NP213)P11-6PC945PolyoxinPradimicins (inc. BMS-181184)R-135853SampangineSM21SPK-843StatinsT-2307TacrolimusTavaborole (AN2690)TipifarnibTurbinmicinVaccinesVT-1129VT-1161VT-1598YO-001A Showing 10 posts of 219 posts found. Title Trail phase Date The Celecoxib Derivative AR-12 Has Broad-Spectrum Antifungal Activity In Vitro and Improves the Activity of Fluconazole in a Murine Model of Cryptococcosis. 1 December 2016 Trans-ungual Delivery of AR-12, a Novel Antifungal Drug. 13 March 2017 ram1 gene, encoding a subunit of farnesyltransferase, contributes to growth, antifungal susceptibility to amphotericin B of Aspergillus fumigatus. 4 February 2017 In vitro antifungal activity of farnesyltransferase inhibitors against clinical isolates of Aspergillus and Candida. 5 December 2013 In vitro antifungal activity of farnesyltransferase inhibitors against clinical isolates of Aspergillus and Candida. 5 December 2013 Evaluation of the antifungal activity of SCY-078 in combination with other antifungals against Aspergillus strains 27 April 2017 Pharmacodynamics of F901318 against Aspergillus fumigatus in a rabbit model of invasive pulmonary aspergillosis (IPA) 27 April 2017 A prospective, phase 2, multicentre, open-label, randomized, comparative study to estimate the safety, tolerability, pharmacokinetics, and efficacy of oral SCY-078 vsstandard-of-care following initial intravenous echinocandin therapy in the treatment of.. Phase 2 27 April 2017 In-vitro activity of F901318 and comparators against clinical isolates of cryptic species of Aspergillus 27 April 2017 Antifungal peptides: a potential new class of antifungals for treating vulvovaginal candidiasis caused by fluconazole-resistant Candida albicans. 24 April 2017 Previous123456789101112131415161718...22Next